Evidence map›Paper›PMID 31208324›Full record

ArticleBMC bioinformatics2019

Machine learning with the TCGA-HNSC dataset: improving usability by addressing inconsistency, sparsity, and high-dimensionality.

Michael C Rendleman, John M Buatti, Terry A Braun, Brian J Smith, Chibuzo Nwakama, Reinhard R Beichel, Bart Brown, Thomas L Casavant

Abstract read
In one paragraph

Article in BMC bioinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Machine learning analysis of TCGA cancer data.PeerJ. Computer science · 2021
    Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael C RendlemanDepartment of Electrical and Computer Engineering, Center for Bioinformatics and Computational Biology, University of Iowa, 5017 Seamans Center, Iowa City, IA, 52242, USA. michael-rendleman@uiowa.edu.ORCID http://orcid.org/0000-0002-7537-263X
John M BuattiDepartment of Radiation Oncology, Carver College of Medicine, University of Iowa Carver College of Medicine, LL-W Pomerantz Family Pavilion, 200 Hawkins Drive, Iowa City, IA, 52242-1089, USA.
Terry A BraunDepartment of Biomedical Engineering, Center for Bioinformatics and Computational Biology, University of Iowa, 5017 Seamans Center, Iowa City, IA, 52242, USA.
Brian J SmithDepartment of Biostatistics, University of Iowa, 145 N. Riverside Drive, 100 CPHB, Iowa City, IA, 52242, USA.
Chibuzo NwakamaDepartment of Electrical and Computer Engineering, Center for Bioinformatics and Computational Biology, University of Iowa, 5017 Seamans Center, Iowa City, IA, 52242, USA.
Reinhard R BeichelIowa Institute for Biomedical Imaging, Department of Electrical and Computer Engineering, Department of Internal Medicine, The University of Iowa, Iowa City, 52242, IA, USA.
Bart BrownCenter for Bioinformatics and Computational Biology, University of Iowa, 5017 Seamans Center, Iowa City, IA, 52242, USA.
Thomas L CasavantDepartment of Electrical and Computer Engineering, Center for Bioinformatics and Computational Biology, University of Iowa, 5017 Seamans Center, Iowa City, IA, 52242, USA.

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Project 4: New Approaches to Improving the Effectiveness of Radionuclide Targeted Treatments in Neuroendocrine TumorsP50CA174521 · NCI · UNIVERSITY OF IOWA · PI ODORISIO, THOMAS · 2015 to 2021
$13.2M
Quantitative Imaging to Assess Response in Cancer Therapy TrialsU01CA140206 · NCI · UNIVERSITY OF IOWA · PI BUATTI, JOHN M, CASAVANT, THOMAS L. · 2010 to 2019
$5.8M
NCI NIH HHS P50 CA174521NCI NIH HHS U01 CA140206NCI NIH HHS U01CA140206
6 · The paper itself

Abstract

backgroundIn the era of precision oncology and publicly available datasets, the amount of information available for each patient case has dramatically increased. From clinical variables and PET-CT radiomics measures to DNA-variant and RNA expression profiles, such a wide variety of data presents a multitude of challenges. Large clinical datasets are subject to sparsely and/or inconsistently populated fields. Corresponding sequencing profiles can suffer from the problem of high-dimensionality, where making useful inferences can be difficult without correspondingly large numbers of instances. In this paper we report a novel deployment of machine learning techniques to handle data sparsity and high dimensionality, while evaluating potential biomarkers in the form of unsupervised transformations of RNA data. We apply preprocessing, MICE imputation, and sparse principal component analysis (SPCA) to improve the usability of more than 500 patient cases from the TCGA-HNSC dataset for enhancing future oncological decision support for Head and Neck Squamous Cell Carcinoma (HNSCC).

resultsImputation was shown to improve prognostic ability of sparse clinical treatment variables. SPCA transformation of RNA expression variables reduced runtime for RNA-based models, though changes to classifier performance were not significant. Gene ontology enrichment analysis of gene sets associated with individual sparse principal components (SPCs) are also reported, showing that both high- and low-importance SPCs were associated with cell death pathways, though the high-importance gene sets were found to be associated with a wider variety of cancer-related biological processes.

conclusionsMICE imputation allowed us to impute missing values for clinically informative features, improving their overall importance for predicting two-year recurrence-free survival by incorporating variance from other clinical variables. Dimensionality reduction of RNA expression profiles via SPCA reduced both computation cost and model training/evaluation time without affecting classifier performance, allowing researchers to obtain experimental results much more quickly. SPCA simultaneously provided a convenient avenue for consideration of biological context via gene ontology enrichment analysis.

Indexed as

Databases, GeneticMachine LearningAlgorithmsArea Under CurveGene OntologyHumansPrincipal Component AnalysisRNA, NeoplasmSquamous Cell Carcinoma of Head and NeckRNA, NeoplasmDecision supportDimensionality reductionGene ontology enrichment analysishnsccMachine learningtcgaUnsupervised transformation

Identifiers

PMID31208324
PMCPMC6580485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.